Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Avoid Marks Electrical Group (MRK) by Steve Moore in ShareProphets
- Buy Atalaya Mining (ATYM) by Canaccord Genuity
- Buy Vaalco Energy, Inc (DI) (EGY) by Canaccord Genuity
- Buy Merit Group (MRIT) by Canaccord Genuity
- Buy Experian (EXPN) by Shore Capital
- Hold Serco Group (SRP) by Shore Capital
- Buy Babcock International Group (BAB) by Shore Capital
- Hold Babcock International Group (BAB) by Berenberg
- Buy Castings (CGS) by Canaccord Genuity
- Hold XPS Pensions Group (XPS) by Shore Capital
- Sell South32 Limited (DI) (S32) by Canaccord Genuity
- Buy Card Factory (CARD) by Christopher Ruane in The Motley Fool
- Avoid Zoo Digital Group (ZOO) by Steve Moore in ShareProphets
- Hold AstraZeneca (AZN) by DZ Bank
- Avoid Facilities by ADF (ADF) by Steve Moore in ShareProphets
- Watch CMC Markets (CMCX) by Jon Smith in The Motley Fool
- Buy Dowlais Group (DWL) by Stephen Wright in The Motley Fool
- Sell Rightmove (RMV) by Citi
- Sell Drax Group (DRX) by Citi
- Buy Ibstock (IBST) by Deutsche Bank
AstraZeneca (AZN) Share Price
Health Care Sector
NOTE: This is based on 1,181 open tips for AstraZeneca (AZN)
| Latest Bid : 10,122.00p | Latest Ask : 10,126.00p |
| High Today : 10,308.00p | Low Today : 10,076.00p |
| This Years High : 13,276.00p | This Years Low : 9,501.00p |
| Volume : 1,249,994 | MKT Cap : £157232M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
AstraZeneca (AZN) Overview
A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.AstraZeneca (AZN) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Hold | DZ Bank | Premium Only | 2024-11-13 13:33:00 13/11/2024 | 0.08% |
| Buy | Goldman Sachs | Premium Only | 2024-11-13 07:20:00 13/11/2024 | -0.92% |
| Buy | Ben McPoland | Premium Only | 2024-11-12 14:20:00 12/11/2024 | 2.25% |
| Overweight | JP Morgan | Premium Only | 2024-11-07 18:00:00 07/11/2024 | 3.03% |
| Buy | Shore Capital | Premium Only | 2024-11-07 15:46:00 07/11/2024 | 4.39% |
AstraZeneca (AZN) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 10,122.00p | Latest Ask : 10,126.00p |
| High Today : 10,308.00p | Low Today : 10,076.00p |
| This Years High : 13,276.00p | This Years Low : 9,501.00p |
| Volume : 1,249,994 | MKT Cap : £157232M |
AstraZeneca Overview
A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest AstraZeneca Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Hold | DZ Bank | Premium Only | 2024-11-13 13:33:00 13/11/2024 | 0.08% |
| Buy | Goldman Sachs | Premium Only | 2024-11-13 07:20:00 13/11/2024 | -0.92% |
| Buy | Ben McPoland | Premium Only | 2024-11-12 14:20:00 12/11/2024 | 2.25% |
| Overweight | JP Morgan | Premium Only | 2024-11-07 18:00:00 07/11/2024 | 3.03% |
| Buy | Shore Capital | Premium Only | 2024-11-07 15:46:00 07/11/2024 | 4.39% |